AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Darbecon 40 Injection

Prescription Icon
Prescription Required

Marketer

Concord Biotech Ltd

Salt Composition

Darbepoetin alfa (40mcg)

Overview Darbecon 40 Injection

Erythropoietin alfa (40 mg) injection treats anemia stemming from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation for increased red blood cell production. This medication demands careful administration due to potential serious adverse reactions; expert medical supervision is crucial. Strict adherence to your physician's instructions is essential. Administration occurs under professional healthcare oversight. Frequently reported side effects encompass abdominal discomfort, hypertension, skin eruptions, injection site pain, dyspnea, cough, and peripheral swelling. Report severe headaches, visual disturbances, nausea, vomiting, or convulsions—indicative of dangerously high blood pressure—immediately. Regular blood tests, monitoring electrolytes (like potassium), hemoglobin, and blood cell counts, will be conducted by your doctor. Discontinue use and seek medical advice if breathlessness or a rash develops. Prior to commencing treatment, disclose any history of heart disease, hypertension, seizures, or strokes. Pregnant, breastfeeding, or intending to conceive or breastfeed individuals should consult their physician regarding the medication's safety profile.

Primary Ingredients of Darbecon 40 Injection

No information provided. Please provide the text you wish to be rewritten.

Uses of Darbecon 40 Injection

Managing anemia associated with chronic kidney failure | Addressing anemia resulting from cancer treatment with chemotherapy

Major Benefits of Darbecon 40 Injection:

This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.

Common Side effects of Darbecon 40 Injection:

  • Abdominal pain
  • High blood pressure
  • Rash
  • Injection site pain
  • Breathlessness
  • Cough
  • Peripheral edema
  • Procedural hypotension (low blood pressure)
  • Convulsion
  • Thromboembolism

How to use Darbecon 40 Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Darbecon 40 Injection works:

Darbecon 40 Injection is an erythropoietin-based medication that boosts red blood cell production. It achieves this by activating the bone marrow, the blood cell-forming tissue within bones, to increase red blood cell generation.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Darbecon 40 Injection may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Darbecon 40 Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administering Darbecon 40 Injection while breastfeeding is likely inadvisable. Preliminary research indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Darbecon 40 Injection.

KidneyKidneySAFE IF PRESCRIBED

Darbecon 40 Injection presents no safety concerns for patients with renal impairment; dose modification is unnecessary.

LiverLiverCAUTION

Patients with hepatic impairment should use Darbecon 40 Injection cautiously, as dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Darbecon 40 Injection :

Should you forget a Darbecon 40 Injection dose, administer it promptly. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Darbecon 40 Injection

LabelValue
Chemical Type Amino Acid and Peptide Analogs
Developing Habits No.
Treatment Category KINSHIP
Actions Erythropoietin-stimulating drug

FAQs on Darbecon 40 Injection

Within 2 to 6 weeks of beginning Darbecon 40 Injection, you should see a rise in your red blood cell count (hemoglobin levels). Consult your doctor with any questions or concerns.
Darbecon 40 Injection carries significant risk, including potentially fatal side effects, and requires expert medical supervision. Treatment should only be administered by a physician experienced with Darbecon 40 Injection, and all instructions must be followed precisely.
Darbecon 40 Injection may be ineffective if you have iron, folic acid, or vitamin B12 deficiencies; these should be addressed. Other factors affecting treatment response include bleeding, infections, inflammation, and bone marrow fibrosis. Consult your doctor for further guidance.
Darbecon 40 Injection treats anemia related to chronic kidney disease in children over one year old. Its effectiveness and side effects in children are comparable to those in adults. Consult your doctor for any concerns.
Darbecon 40 Injection can influence blood pressure. Blood pressure monitoring is essential during initial treatment; individuals with hypertension should manage their condition accordingly. The doctor may discontinue Darbecon 40 Injection if blood pressure remains uncontrolled.
Darbecon 40 Injection should not be used by individuals without a doctor's prescription. It is also contraindicated for patients with uncontrolled hypertension, a history of pure red cell aplasia (PRCA) triggered by Darbecon 40 Injection or similar medications, or a history of serious allergic reactions to this drug.
Darbecon 40 Injection
2,159
MRP 2,499
13% off